Breaking News Instant updates and real-time market news.

ROKU

Roku

$61.10

2.91 (5.00%)

, ZSAN

Zosano Pharma

$3.77

0.105 (2.86%)

10:30
04/23/19
04/23
10:30
04/23/19
10:30

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Roku (ROKU) initiated with a Positive at Susquehanna. 2. Zosano Pharma (ZSAN) initiated with an Overweight at Cantor Fitzgerald. 3. Trade Desk (TTD) initiated with a Hold at Needham. 4. SQM (SQM) initiated with a Sell at Vertical Group. 5. Lyft (LYFT) initiated with an Outperform at JMP Securities, Raymond James, Cowen, and Credit Suisse, an Overweight at JPMorgan and Piper Jaffray, a Buy at Jefferies, Canaccord, and Stifel, and a Sector Weight at KeyBanc. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ROKU

Roku

$61.10

2.91 (5.00%)

ZSAN

Zosano Pharma

$3.77

0.105 (2.86%)

TTD

Trade Desk

$208.56

-2.58 (-1.22%)

SQM

SQM

$36.20

-0.88 (-2.37%)

LYFT

Lyft

$59.90

-1.01 (-1.66%)

  • 30

    Apr

  • 07

    May

  • 08

    May

  • 09

    May

  • 22

    May

  • 23

    May

ROKU Roku
$61.10

2.91 (5.00%)

04/22/19
SUSQ
04/22/19
INITIATION
Target $80
SUSQ
Positive
Roku initiated with a Positive at Susquehanna
Susquehanna analyst Shyam Patil initiated Roku with a Positive and $80 price target.
04/12/19
RHCO
04/12/19
NO CHANGE
RHCO
Disney+ not a 'strong alternative' to Netflix, says SunTrust
SunTrust analyst Matthew Thornton keeps his Buy rating on Netflix (NFLX) after Disney's (DIS) Disney+ investor day presentation, saying that while he continues to view the platform posing incremental competition for new subscriber adds, he expects it to be "manageable". The analyst notes that the Disney+ event contained "no big surprises in terms of pricing, timing, availability, and content", adding that the accelerated cord-cutting from the launch should also be positive for Netflix, which offers a "much broader range of content". Thornton further states that Disney+ should be a "modest incremental positive" for his Buy-rated Roku (ROKU) as it will be available for sale on its platform given its "potential for direct monetization."
04/08/19
04/08/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. General Electric (GE) downgraded to Underweight from Neutral at JPMorgan with analyst Stephen Tusa saying with the stock up 38% year-to-date, many investors are underestimating the severity of the challenges and underlying risks at GE, while overestimating the value of "small positives." 2. Starbucks (SBUX) downgraded to Neutral from Buy at UBS with analyst Dennis Geiger saying the risk/reward on shares "appears balanced" with the stock up 55% since June. 3. Boeing (BA) downgraded to Neutral from Buy at BofA/Merrill with analyst Ronald Epstein citing the company's announcement that it will cut 737 production rates to 42 per month from 52 per month, which he takes to likely mean that the 737 delay could last longer than previously expected. 4. Micron (MU) downgraded to Market Perform from Outperform at Cowen with analyst Karl Ackerman saying his field work indicates Micron's profitability will decline again in calendar year 2020. 5. Roku (ROKU) downgraded to Sell from Neutral at Citi with analyst Mark May saying the stock is up 110% year-to-date and near all-time highs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/08/19
SBSH
04/08/19
DOWNGRADE
Target $50
SBSH
Sell
Citi downgrades Roku to Sell with $50 target after 110% year-to-date rally
Citi analyst Mark May downgraded Roku to Sell from Neutral and lowered his price target for the shares to $50 from $53. The stock is up 110% year-to-date and near all-time highs, May tells investors in a research note. The analyst notes Roku trades at a 70% premium to peers and believes that recent changes in the over-the-top streaming landscape could create greater competition. Further, Roku's Platform segment revenue growth could be impacted this year due to tough comps, May tells investors in a research note.
ZSAN Zosano Pharma
$3.77

0.105 (2.86%)

02/21/19
BTIG
02/21/19
NO CHANGE
BTIG
Buy
BTIG boosts Zosano target to $19 on 'solid' migraine safety data
BTIG analyst Robert Hazlett raised his price target for Zosano Pharma to $19 and keeps a Buy rating on the shares. The stock in morning trading is up 95%, or $2.10, to $4.31. Zosano's 12-month safety study of Qtrypta, its novel acute migraine therapeutic, demonstrates "rapid, robust, and durable efficacy," Hazlett tells investors in a research note. He believes the study announced this morning should finalize the clinical requirements for a New Drug Application in Q4. The data continue to support Qtrypta's "meaningful potential" as an acute migraine treatment, particularly for those with nausea or with difficult-to-treat migraine, says Hazlett. He estimates Qtrypta's approval in 2020 with U.S. peak revenue of ~$300M. The analyst estimates Zosano's standalone net present value at $16.94 per share, and the company's potential as a takeover target boosts his price target to $19.
04/17/19
MAXM
04/17/19
INITIATION
Target $8
MAXM
Buy
Zosano Pharma initiated with a Buy at Maxim
Maxim analyst Anthony Vendetti initiated Zosano Pharma with a Buy rating and a price target of $8, citing the company's "innovative drug delivery platform" to be used initially in migraine treatments which he estimates to be about a $1B market. The analyst also points to Zosano Pharma's products' "superior clinical efficacy and safety profiles" as well as their "ease of use", anticipating the company to submit a New Drug Application with the FDA by Q4 of 2020.
04/22/19
CANT
04/22/19
INITIATION
Target $12
CANT
Overweight
Zosano Pharma initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan initiated Zosano Pharma with an Overweight and $12 price target.
04/23/19
CANT
04/23/19
INITIATION
Target $12
CANT
Overweight
Cantor starts Zosano Pharma with Overweight rating, $12 price target
Cantor Fitzgerald analyst Charles Duncan last night initiated coverage of Zosano Pharma with an Overweight rating and $12 price target. The company's proprietary delivery platform facilitates rapid transcutaneous absorption of drug candidates and is applicable to multiple therapeutic areas, including migraine and other acute symptom settings, and is appropriate for several classes of drugs, Duncan tells investors in a research note. Zosano is on track to file its first new drug application by the end of 2019 with Qtrypta, a drug that has demonstrated "impressive" Phase 3 clinical data, adds the analyst.
TTD Trade Desk
$208.56

-2.58 (-1.22%)

04/23/19
NEED
04/23/19
INITIATION
NEED
Hold
Trade Desk initiated with a Hold at Needham
Needham analyst Laura Martin initiated Trade Desk (TTD) with a Hold rating, citing the company's competitive position relative to "Walled Gardens" advertising ecosystem, strong client relationships, and an "outstanding execution track record of strong fundamental growth." The analyst also notes that she is concerned the possibility of an "economic or ad recession", higher working capital demands, and competition. Martin adds that when valued next to other companies driven by the shift toward over-the-top media content like Netflix (NFLX) and Roku (ROKU), Trade Desk shares trade at a premium.
03/27/19
JEFF
03/27/19
NO CHANGE
Target $200
JEFF
Buy
Jefferies still bullish on Trade Desk's long-term prospects amid Chrome talk
Trade Desk (TTD) shares have dropped amid rumors of Google (GOOG, GOOGL) potentially limiting third party cookies in Chrome, Jefferies analyst Brent Thill tells investors in a research note. The analyst says that with the stock up 60% year-to-date, he understands "uncertainty causing a pullback." However, he believes Trade Desk's position as a "scaled, independent, omnichannel platform" positions it to aid advertisers in an evolving high velocity landscape. After speaking to industry contacts, Thill says details remain sparse on any potential changes. Nonetheless, he remains bullish on Trade Desk's long-term prospects and keeps a Buy rating on the shares with a $200 price target.
03/27/19
STFL
03/27/19
NO CHANGE
STFL
Trade Desk reaction to Google report overdone, says Stifel
Stifel analyst John Egbert noted that shares of both Trade Desk (TTD) and Criteo (CRTO) fell significantly on both Monday and Tuesday due to an Adweek report that Google (GOOGL) is considering significant changes to its consumer-facing products and advertising tools to better protect users' data privacy. He thinks the negative reaction in shares of Trade Desk seems overdone, stating that its ad business is not overly reliant on invasive forms of user tracking or ad targeting. Egbert noted that Trade Desk saw "almost no impact" from Apple's (AAPL) ITP rollout and the implementation of General Data Protection Regulation, or GDPR, in Europe. However, the even stronger negative reaction in shares of Criteo (CRTO) was more warranted, said Egbert, as the majority of its business is exposed to mobile and desktop Chrome browsers in some way. Speculation over Chrome changes will likely be an overhang on Criteo shares until Google makes its plans known, though investors should grow comfortable with Trade Desk's exposure to changes in privacy policies that could actually benefit the company over time, concluded Egbert. He maintains Hold ratings on both Trade Desk and Criteo.
04/22/19
NEED
04/22/19
INITIATION
NEED
Hold
Trade Desk initiated with a Hold at Needham
Needham analyst Laura Martin initiated Trade Desk with a Hold rating.
SQM SQM
$36.20

-0.88 (-2.37%)

04/03/19
SANT
04/03/19
DOWNGRADE
SANT
Hold
SQM downgraded to Hold from Buy at Santander
04/12/19
MSCO
04/12/19
NO CHANGE
Target $35
MSCO
Underweight
SQM price target lowered to $35 from $44 at Morgan Stanley
Morgan Stanley analyst Javier Martinez de Olcoz Cerdan cut his price target on SQM (SQM) shares to $35 from $44 and keeps an Underweight rating on the stock after meeting with the company's new CEO, Corfo, the ministry of mining and other industry contacts in Chile. Following his visit, he is less optimistic about both the possibility of an early lease renewal and the pace of SQM's medium-term expansion, he said, adding that he sees significant potential downside to SQM's consensus forecasts. The analyst continue to see downside to consensus lithium price expectations and also keeps an Underweight rating on Albemarle (ALB).
04/15/19
SBSH
04/15/19
DOWNGRADE
Target $13
SBSH
Neutral
Citi sees lithium as 'buyer's market,' downgrades Livent to Neutral from Buy
Citi analyst P.J. Juvekar downgraded Livent (LTHM) to Neutral from Buy and lowered his price target for the shares to $13 from $15. The analyst also reduced his price target for Neutral-rated Albemarle (ALB) to $88 from $92. Following a site visit to the Salar de Atacama and meetings with SQM's (SQM) CFO, Juvekar gets the sense that the lithium market "has become a buyer's market." Chinese buyers seem to have become more aggressive and China's new energy vehicle subsidy cuts may weigh on the market beginning in the second half of 2019, the analyst tells investors in a research note. While Albemarle and Livent's volumes are secured under multi-year terms, pricing for future volumes could come under pressure as new conversion capacity ramps up in 2019-2020, contends Juvekar. He reduced his valuation multiples for both stocks as "competition in the lithium market increases."
04/22/19
VERF
04/22/19
INITIATION
Target $23
VERF
Sell
SQM initiated with a Sell at Vertical Group
Vertical Group analyst James Bardowski started SQM with a Sell rating and $23 price target. The company has relatively high exposure to lithium spot markets, where prices are at risk of moving lower as supply outpaces demand near-term and an end to China's new energy vehicles subsidies comes into sight, Bardowski tells investors in a research note. Further, increased spending at SQM "will stretch an already limited balance sheet," adds the analyst.
LYFT Lyft
$59.90

-1.01 (-1.66%)

04/23/19
KEYB
04/23/19
INITIATION
KEYB
Sector Weight
Lyft initiated with a Sector Weight at KeyBanc
KeyBanc analyst Andy Hargreaves started coverage of Lyft with a Sector Weight. While the analyst acknowledges that Lyft holds a "unique and valuable strategic position" in North American ride-sharing, he believes the large cost gap between owned cars and ride-sharing suggests that a significant portion of its profit potential will be unlocked only after the driver is removed, which likely remains several years away. In the meantime, Hargreaves expects steady deceleration in market growth and Lyft's pace of share gain, which seems likely to prevent revenue and adjusted EBITDA from meaningfully exceeding his expectations.
04/23/19
COWN
04/23/19
NO CHANGE
Target $160
COWN
Underperform
Tesla price target lowered to $160 from $170 at Cowen
Cowen analyst Jeffrey Osborne maintained an Underperform rating on Tesla (TSLA) and lowered his price target to $160 from $170 following the company's "Autonomy Day" event, saying he sees a significant amount of technology and execution risk in the shift in strategy from competing in just electrification to also beating Nvidia (NVDA) in hardware, Google (GOOGL) in software, and building a better ride-hailing service than current leaders in the sector.
04/23/19
JMPS
04/23/19
INITIATION
Target $78
JMPS
Outperform
Lyft initiated with an Outperform at JMP Securities
JMP Securities analyst Ronald Josey initiated Lyft with an Outperform rating and $78 price target, noting that the ridesharing market is increasingly becoming a duopoly and he believes Lyft can continue to grow faster than the market while acting "more rationally" with marketing, promotions, and incentives. Josey also sees near-term upside from new products and services, such as bikes and scooters, and longer-term from autonomous vehicles, he added.
04/23/19
JEFF
04/23/19
INITIATION
Target $86
JEFF
Buy
Lyft initiated with a Buy at Jefferies
Jefferies analyst Brent Thill initiated Lyft (LYFT) with a Buy rating and $86 price target, stating that the post-IPO slide in the stock has driven its valuation to the bottom fifth of its peer group despite growth that is in the top fifth of the group. He believes that Lyft's "outsized" 39% share in a ridesharing duopoly with Uber (UBER) is durable and he sees "plenty of runway left" given that the market is only 1% penetrated in terms of miles driven.

TODAY'S FREE FLY STORIES

AAPL

Apple

$202.73

-9.82 (-4.62%)

, AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

09:03
08/24/19
08/24
09:03
08/24/19
09:03
Periodicals
Costco the most 'woke' company out there, Barron's says »

Earlier this week, the…

AAPL

Apple

$202.73

-9.82 (-4.62%)

AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

BLK

BlackRock

$407.29

-11.55 (-2.76%)

WMT

Walmart

$110.83

-1.07 (-0.96%)

COST

Costco

$274.16

-5.7 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 25

    Sep

  • 03

    Oct

  • 27

    Oct

  • 13

    Nov

  • 14

    Nov

MMM

3M

$155.84

-5.04 (-3.13%)

08:58
08/24/19
08/24
08:58
08/24/19
08:58
Periodicals
3M stock still not looking like a bargain, Barron's says »

3M shares are down by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ULTA

Ulta Beauty

$322.34

-12.5 (-3.73%)

08:56
08/24/19
08/24
08:56
08/24/19
08:56
Periodicals
Ulta Beauty bucking downbeat retail trends, Barron's says »

Ulta Beauty has been one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 25

    Sep

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$42.47

-1.29 (-2.95%)

08:49
08/24/19
08/24
08:49
08/24/19
08:49
Periodicals
Roku working for investors, Barron's says »

The streaming war…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$42.47

-1.29 (-2.95%)

DIS

Disney

$131.70

-4.37 (-3.21%)

NFLX

Netflix

$291.40

-5.47 (-1.84%)

AAPL

Apple

$202.73

-9.82 (-4.62%)

ROKU

Roku

$137.77

-1.35 (-0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

  • 23

    Sep

  • 27

    Oct

NSRGY

Nestle

$0.00

(0.00%)

08:44
08/24/19
08/24
08:44
08/24/19
08:44
Periodicals
Nestle stock looking appetizing after big gain, Barron's says »

Nestle is having a great…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$291.40

-5.47 (-1.84%)

, DIS

Disney

$131.70

-4.37 (-3.21%)

08:39
08/24/19
08/24
08:39
08/24/19
08:39
Periodicals
Football season is back, key moment for TV future, Barron's says »

On Sept. 5, when the…

NFLX

Netflix

$291.40

-5.47 (-1.84%)

DIS

Disney

$131.70

-4.37 (-3.21%)

FOXA

Fox Corp.

$31.76

-1.29 (-3.90%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$42.47

-1.29 (-2.95%)

CBS

CBS

$41.39

-2.06 (-4.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 23

    Sep

  • 27

    Oct

AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

, FDX

FedEx

$151.94

-6.17 (-3.90%)

08:05
08/24/19
08/24
08:05
08/24/19
08:05
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

FDX

FedEx

$151.94

-6.17 (-3.90%)

UPS

UPS

$111.29

-3.91 (-3.39%)

F

Ford

$8.76

-0.27 (-2.99%)

GM

General Motors

$36.06

-1.19 (-3.19%)

DDAIF

Daimler AG

$0.00

(0.00%)

HMC

Honda

$22.90

-0.32 (-1.38%)

TM

Toyota

$127.94

-1.69 (-1.30%)

VWAGY

Volkswagen

$0.00

(0.00%)

AAPL

Apple

$202.73

-9.82 (-4.62%)

FB

Facebook

$177.69

-4.39 (-2.41%)

TWTR

Twitter

$41.01

-1.16 (-2.75%)

GOOGL

Alphabet Class A

$1,154.66

-35.75 (-3.00%)

GOOG

Alphabet

$1,151.72

-36.81 (-3.10%)

ADM

Archer Daniels

$37.44

-0.48 (-1.27%)

REGI

Renewable Energy

$11.65

0.61 (5.53%)

GPRE

Green Plains

$7.34

-0.68 (-8.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 17

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 23

    Sep

  • 24

    Sep

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 13

    Nov

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

, AMD

AMD

$29.55

-2.35 (-7.37%)

04:55
08/24/19
08/24
04:55
08/24/19
04:55
Conference/Events
MUFG Securities to hold a tour »

MUFG Securities Tech Tour…

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

AMD

AMD

$29.55

-2.35 (-7.37%)

ANET

Arista Networks

$223.35

-3.84 (-1.69%)

CHKP

Check Point

$106.84

-2.36 (-2.16%)

CSCO

Cisco

$46.65

-1.55 (-3.22%)

EQIX

Equinix

$549.81

-4.27 (-0.77%)

FLEX

Flex

$9.72

-0.54 (-5.26%)

INTC

Intel

$44.97

-1.79 (-3.83%)

NVDA

Nvidia

$162.51

-8.93 (-5.21%)

OTEX

OpenText

$38.54

-0.57 (-1.46%)

PYPL

PayPal

$106.08

-2.66 (-2.45%)

RNG

RingCentral

$141.50

-0.86 (-0.60%)

SQ

Square

$61.65

-3 (-4.64%)

STX

Seagate

$46.96

-0.62 (-1.30%)

TWLO

Twilio

$127.90

-2.585 (-1.98%)

V

Visa

$175.24

-4.91 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 09

    Sep

  • 10

    Sep

  • 16

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 10

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

, COF

Capital One

$83.06

-2.68 (-3.13%)

17:57
08/23/19
08/23
17:57
08/23/19
17:57
Periodicals
Deutsche Bank, Capital One won't say if they have Trump's tax returns, NYP says »

Deutsche Bank (DB) and…

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

COF

Capital One

$83.06

-2.68 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MXIM

Maxim Integrated

$52.14

-2.42 (-4.44%)

17:53
08/23/19
08/23
17:53
08/23/19
17:53
Hot Stocks
Maxim Integrated's Jain sells 12,683 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

GLD

SPDR Gold Shares

$144.15

2.77 (1.96%)

17:42
08/23/19
08/23
17:42
08/23/19
17:42
Hot Stocks
SPDR Gold Shares holdings rise to 859.83MT to 854.84MT »

This is the fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUMN

Golden Minerals

$0.27

0.0159 (6.38%)

17:33
08/23/19
08/23
17:33
08/23/19
17:33
Hot Stocks
Golden Minerals receives noncompliance notice from NYSE »

Golden Minerals announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMPI

DelMar Pharmaceuticals

$0.77

0.0047 (0.61%)

17:25
08/23/19
08/23
17:25
08/23/19
17:25
Hot Stocks
Intracoastal Capital reports 9.99% passive stake in DelMar Pharmaceuticals »

Intracoastal Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$180.58

-6.44 (-3.44%)

17:22
08/23/19
08/23
17:22
08/23/19
17:22
Hot Stocks
Raytheon awarded $534M Army contract »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHAL

Amerco

$339.43

-2.97 (-0.87%)

17:21
08/23/19
08/23
17:21
08/23/19
17:21
Hot Stocks
Amerco announces special cash dividend of 50c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTLA

Intellia Therapeutics

$15.77

-1.08 (-6.41%)

17:20
08/23/19
08/23
17:20
08/23/19
17:20
Syndicate
Breaking Syndicate news story on Intellia Therapeutics »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$183.42

-4.19 (-2.23%)

17:19
08/23/19
08/23
17:19
08/23/19
17:19
Hot Stocks
General Dynamics awarded $1.08B Navy contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVLN

Novelion Therapeutics

$0.66

-0.0523 (-7.37%)

17:17
08/23/19
08/23
17:17
08/23/19
17:17
Hot Stocks
Stonepine Capital reports 6.1% passive stake in Novelion Therapeutics »

Stonepine Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$376.85

-8.91 (-2.31%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Hot Stocks
Lockheed Martin awarded $2.43B Navy contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$1.84

-0.03 (-1.60%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Syndicate
Breaking Syndicate news story on OncoSec »

OncoSec files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.42

-0.0249 (-5.60%)

17:09
08/23/19
08/23
17:09
08/23/19
17:09
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

17:08
08/23/19
08/23
17:08
08/23/19
17:08
General News
Trump to raises tariff rates on Chinese goods, CNBC says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATIS

Attis Industries

$1.03

-0.08 (-7.21%)

17:06
08/23/19
08/23
17:06
08/23/19
17:06
Hot Stocks
Attis Industries provides update on status of Nasdaq listing »

Attis Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVEO

Civeo

$1.32

-0.07 (-5.04%)

17:04
08/23/19
08/23
17:04
08/23/19
17:04
Syndicate
Breaking Syndicate news story on Civeo »

Civeo files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGO

Assured Guaranty

$42.56

-1.09 (-2.50%)

16:58
08/23/19
08/23
16:58
08/23/19
16:58
Hot Stocks
Assured Guaranty CEO sells 30,300 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.